FinancialBuzz.com’s latest


The Buzz


Show: Featuring Our Corporate News Recap on “ReWalk Robotics, Ltd.


Awarded Device


Designation by the US Food and Drug Administration”

ReWalk Robotics, Ltd.



(NASDAQ: RWLK)




surged over 36% in premarket trading after the company was granted designation as a Breakthrough Device by the US Food and Drug Administration.

The ReBoot is a lightweight, battery-powered orthotic exo-suit intended to assist ambulatory functions in individuals with reduced ankle function related to neurological injuries, and the breakthrough designation provides a more streamlined review pathway for the device.

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.

For more information, please visit:


ReWalk Robotics, Ltd.

About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.

The post

“The Buzz” Show: ReWalk Robotics, Ltd. (NASDAQ: RWLK) Device Designation by the US FDA

first appeared on

Financial Buzz

.

For further details see:

“The Buzz” Show: ReWalk Robotics, Ltd. (NASDAQ: RWLK) Device Designation by the US FDA